Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-034430

Chief Operations Officer sold 2,453 shares at $14.55 ($35,691)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Newell Joe Chief Operations Officer 2021-05-18 Sale −2,453 $14.55 $35,691 128,971 D: show line 1 in the form
Open-market sales · 2,453 sh · avg $14.55 · $35,691
Loading xslF345X03/doc4.xml…